Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2025)

Lexaria Bioscience has disclosed Short-term Investments across 8 years of filings, most recently posting $143267.0 for Q4 2025.

• Short-term Investments for Q4 2025 came in at $143267.0, up 259.29% year-over-year; the trailing twelve-month figure through Nov 2025 was $143267.0 (up 259.29% YoY), and the FY2025 annual result was $143267.0, up 156.72% from the prior year.
• Short-term Investments came in at $143267.0 for Q4 2025 at Lexaria Bioscience, roughly flat from $143267.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $833841.0 in Q3 2021 to a low of $33540.0 in Q2 2025.
• The 5-year median for Short-term Investments is $205485.5 (2023), against an average of $250752.1.
• Across the five-year window, Short-term Investments soared 4215.72% in 2021 and plunged 82.82% in 2024, its largest moves.
• Lexaria Bioscience's Short-term Investments stood at $493424.0 in 2021, then tumbled by 45.34% to $269707.0 in 2022, then tumbled by 73.15% to $72427.0 in 2023, then plunged by 44.94% to $39875.0 in 2024, then surged by 259.29% to $143267.0 in 2025.
• The last three Short-term Investments figures came in at $143267.0 (Q4 2025), $143267.0 (Q3 2025), and $33540.0 (Q2 2025), per Business Quant data.